Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Suction-assisted flexible RIRS versus PCNL for 2–3 cm kidney stones

Official title: A Multicenter, Randomized Controlled Trial Comparing the Retrograde Intrarenal Surgery With a Tip-Flexible Suction Access Sheath to the Standard Percutaneous Nephrolithotomy for the Treatment of 2-3 cm Unilateral Renal Stones

Run by Changhai Hospital · NCT07058402 · Data updated 2026-11-12

This study will test whether a suction-assisted flexible RIRS removes 2–3 cm kidney stones as effectively and safely as standard PCNL in adults.

More Nephrolithiasis trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment308 (estimated)
SponsorChanghai Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 1, 2025
Main results expectedApril 30, 2026
Study endsJune 30, 2026
Registry record updatedJuly 10, 2025
Trial IDNCT07058402 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with a single unilateral kidney stone measuring 2–3 cm on CT, ASA I–III, who can give informed consent and comply with follow-up are ideal candidates.

Probably not a fit

Patients with abnormal urinary tract anatomy, uncontrolled urinary infection, absolute contraindications to RIRS or PCNL, urgent surgical needs, or inability to follow the protocol are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial will enroll 308 adults with a single 2–3 cm kidney stone and randomize them to either retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath (TFS-UAS) or standard percutaneous nephrolithotomy (PCNL). The TFS-UAS is designed to improve access to renal calyces, reduce intrarenal pressure, and evacuate stone fragments by continuous suction to potentially increase stone clearance during RIRS. The primary endpoint is stone-free rate at 3 months measured by CT, and secondary outcomes include postoperative infection rates, changes in hemoglobin and procalcitonin, hospital stay duration, and pain scores. Procedures and follow-up will be carried out at four tertiary centers in China with standardized protocols.

Why it matters

Potential benefit: If successful, suction-assisted RIRS could offer a less invasive way to clear medium-sized kidney stones with similar or fewer complications and shorter hospital stays compared with PCNL.

How similar studies have gone: PCNL is an established effective treatment for 2–3 cm stones while conventional RIRS has shown lower stone-free rates for larger stones; suction-assisted sheaths are a novel modification with limited prior clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 80 years
2. American Society of Anesthesiologists (ASA) physical status classification of I-III
3. Single renal stone with a diameter between 2-3 cm confirmed by non-contrast CT scan
4. Signed written informed consent and willingness to comply with study procedures

Exclusion Criteria:

1. Anatomical abnormalities of the urinary tract (e.g., horseshoe kidney, ileal conduit)
2. Uncontrolled urinary tract infection
3. Absolute contraindications for RIRS or PCNL
4. Inability to understand or complete study documentation
5. Failure to follow study protocol or attend follow-up
6. Patients requiring urgent rescue or at high risk for irreversible harm during surgery
7. Patients who voluntarily withdraw from the study

Where it's running

  • Changhai Hospital, Naval Medical University
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.